Keyphrases
Pharmacodynamics
100%
Acute Myeloid Leukemia
100%
Targeted Therapy
100%
Histone
100%
Dephosphorylation
100%
17-AAG
100%
Flavopiridol
100%
Phosphorylation
75%
Kinase Activity
75%
Histone H1
75%
Histone Phosphorylation
50%
Phosphoproteomics
50%
Kasumi-1
50%
In Cancer
25%
Histone Deacetylase Inhibitor (HDACi)
25%
Drug Action
25%
Casein
25%
In Vitro Activity
25%
Protease Inhibitors
25%
Lysate
25%
Leukemia Cell Lines
25%
Phosphoprotein
25%
Cellular Response
25%
Phosphorylation Sites
25%
Cyclin-dependent Kinase Inhibitor
25%
Specific Enzymes
25%
Acute Myeloid Leukemia Cells
25%
Pharmacodynamic Markers
25%
Informative Markers
25%
Direct Analysis
25%
H1.2
25%
Heat Shock Protein 90 Inhibitor
25%
LC-MS Profiling
25%
Cancerous Transformation
25%
Nucleoside Analogues
25%
Independent Treatment
25%
17-allylamino-17-demethoxygeldanamycin
25%
H1 Variants
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacodynamics
100%
Histone
100%
Flavopiridol
100%
Acute Myeloid Leukemia
100%
Phosphotransferase
75%
Histone H1
75%
Malignant Neoplasm
25%
Histone Deacetylase Inhibitor
25%
Casein
25%
Phosphoprotein
25%
Cyclin Dependent Kinase Inhibitor
25%
Heat Shock Protein 90 Inhibitor
25%
Tanespimycin
25%
Biochemistry, Genetics and Molecular Biology